Global Blood Therapeutics Company Profile

01:08 EDT 19th June 2018 | BioPortfolio

Global Blood Therapeutics is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and genetic disorders for which there are currently no available cures and only extremely limited therapeutic options. The company’s SHAPE Platform enables the discovery and development of oral, small molecule drugs that change the shapes of key blood proteins to modify their functions, enhance vital biological pathways and drive therapeutic benefits. Global Blood Therapeutics’ approach combines the most advanced computational biology and protein-ligand modeling with medicinal chemistry and empiric screening capabilities focused on allosteric modulation, while leveraging its team’s world-leading expertise in blood biology and proven success in drug discovery and development. Global Blood Therapeutics is a private company launched in 2012 by Third Rock Ventures with an experienced leadership team and renowned scientific founders. For more information, please visit

News Articles [2299 Associated News Articles listed on BioPortfolio]

Global Blood Therapeutics Stock Breaks Out, These Are the Implications

GBT Stock: Higher Prices Are Now in Development It didn't take long to vindicate my bullish stance on Global Blood Therapeutics Inc (NASDAQ:GBT) stock, because the same day my report, "Eyeing These...

Global Blood nets $240.8mm through public stock offering

Global Blood Therapeutics Inc. netted $240.8mm through a public offering of 4.6mm common shares (including the overallotment) at $54. The company is developing treatments for blood-based diseases, and...

Follow-on funding raises $216M for Global Blood

A follow-on funding brought in $216 million for sickle cell company Global Blood Therapeutics, which has ongoing Phase III an -More- 

Global Blood Therapeutics: Potential To Enhance Blood Flow In Patients And Money Flow For Investors

Global Blood Therapeutics (GBT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

Global Blood Therapeutics: The Significance Of ASH Updates

Global Blood Therapeutics: Grade 'A' Opportunity

Global Blood Therapeutics: The Anatomy Of A Senseless Drop

PubMed Articles [3305 Associated PubMed Articles listed on BioPortfolio]

Therapeutics Incorporating Blood Constituents.

Blood deficiency and dysfunctionality can result in adverse events, which can primarily be treated by transfusion of blood or the re-introduction of properly functioning sub-components. Blood constitu...

May Measurement Month 2017: an analysis of blood pressure screening results worldwide.

Increased blood pressure is the biggest contributor to the global burden of disease and mortality. Data suggest that less than half of the population with hypertension is aware of it. May Measurement ...

Effect of perindopril and bisoprolol on IL-2, INF-γ, hs-CRP, and T-cell stimulation and its correlations with blood pressure in mild and moderate hypertension

Cardiovascular disease is the leading global cause of death. Its development is largely determined by lifestyle and cardiovascular risk factors, among which arterial hypertension (HT) plays a key role...

Assessment of relationship of ABO blood groups among tobacco induced oral cancer patients of Kanpur Population, Uttar Pradesh.

The possibility of association between ABO blood groups and malignancy was first discussed by Anderson DE & Haas C. The association between blood group and oral cancer is least explored and hence this...

Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.

Clinical Trials [4299 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Global Congestive Heart Failure Registry

Heart failure (HF) is a major health problem worldwide but there is no global HF study that documents demographics, socioeconomic and clinical factors, diagnostic and management patterns, ...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Cryo AF Global Registry

Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market Registry

Companies [2709 Associated Companies listed on BioPortfolio]

Global Blood Therapeutics

Global Blood Therapeutics is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and genetic...


For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:Donor Products - These products are marketed to the blood donation...

Synthetic Blood International, Inc

Synthetic Blood International, Inc. (OTC BB: SYBD) is a cutting edge biomedical product development company specializing in creating innovative pharmaceuticals and medical devices in the fields of oxy...

ZymeQuest Incorporated

ZymeQuest, a development stage company, is the global leader in the discovery, development and commercialization of enzymatic blood conversion products for use in blood transfusion medicine. Our enzym...


CaridianBCT is the leading global provider of innovative technologies and services specializing in automated blood collections, therapeutic apheresis and cell therapy systems, who...

More Information about "Global Blood Therapeutics" on BioPortfolio

We have published hundreds of Global Blood Therapeutics news stories on BioPortfolio along with dozens of Global Blood Therapeutics Clinical Trials and PubMed Articles about Global Blood Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Blood Therapeutics Companies in our database. You can also find out about relevant Global Blood Therapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record